Motoric Cognitive Risk Syndrome: Prevalence and Risk of Cognitive Impairment in a Population Studied in the Mexican Health and Aging Study 2012-2015
The aim of this study was to determine the prevalence of Motoric Cognitive Risk (MCR) syndrome, describe associated risk factors and to determine the risk of progression to cognitive impairment after three years of follow-up, in a sample of Mexican older adults.
A prospective panel study of health and aging in Mexico.
Setting and participants
Baseline and follow-up information was obtained from the Mexican Health and Aging Study’s 2012 and 2015 waves. A total of 726 subjects aged 60 years or older with normal cognition at baseline were classified into 4 groups: 1) with MCR, 2) with memory complaint only, 3) with slow gait speed only and, 4) without MCR. Cox regression analysis controlling for confounder factors was performed to determine the risk of progression to cognitive impairment in the MCR group.
Data such as gait speed, functional status and cognitive performance (standardized by age and sex in Mexican population) was collected.
MCR prevalence was 14.3%. When compared with non-MCR subjects, the presence of MCR was associated with older age (p<0.01), lower educational status (p=0.05), having two or more comorbidities (p<0.05) and diabetes mellitus diagnosis (p<0.05). At follow-up and after adjusting for confounders, MCR was associated with a 2.4-fold increased risk (95% CI: 1.28-4.26, p=.000) of cognitive impairment.
MCR syndrome increases the risk of cognitive impairment in Mexican older adults. Simple measurements such as gait evaluation in subjects with memory complaints could allow early identification of those at risk of developing cognitive impairment.
Key wordsCognitive complaints slow gait activities of daily living cognitive impairment older adult
- 1.Instituto Nacional de Estadística, Geografía e Informática. Estadísticas a propósito del día internacional de las personas de la tercera edad. INEGI. https://doi.org/www.inegi.org.mx/saladeprensa/aproposito/2014/adultos0.pdf. Accessed 11 September 2017
- 2.Organización Panamericana de la Salud. Encuesta Multicéntrica, Salud Bienestar y Envejecimiento (SABE) en América Latina y el Caribe, 2001. https://doi.org/envejecimiento.csic.es/documentos/documentos/paho-salud-01.pdf. Accessed 11 September 2017
- 3.Mejía S, Miguel-Jaimes A, Villa A, Ruiz L, Gutiérrez LM. Cognitive impairment and associated factors in older adults in Mexico. Salúd Publica Mex 2007;49 suppl 4, 475-481Google Scholar
- 4.Solomon PR, Murphy CA. Should we screen for Alzheimer’s disease? A review of the evidence for and against screening Alzheimer’s disease in primary care practice. Geriatrics 2005;60:26–31Google Scholar
- 5.Prince M, Acosta D, Ferri CP, et al. Dementia incidence and mortality in middle-income countries, and associations with indicators of cognitive reserve:a 10/66 Dementia Research Group population-based cohort study. Lancet 2005;7;380(9836):50-8Google Scholar
- 6.Bush C, Kozak J, Elmslie T. Screening for cognitive impairment in the elderly. Can Fam Physician 1997;43:1763–8Google Scholar
- 7.Doraiswamy PM, Steffens DC, Pitchumoni S, et al. Early recognition of Alzheimer’s disease:what is consensual? What is controversial? What is practical? J Clin Psychiatry 1998;59 Suppl 13:6–18Google Scholar
- 9.Montero M, Bergman H, Phillips NA, et al. Dual-tasking and gait in people with mild cognitive impairment. The effect of working memory. BMC Geriatr 2009;9:41Google Scholar
- 10.Wong R, Espinoza M, Palloni A. Adultos mayores mexicanos en contexto socioeconómico amplio:salud y envejecimiento. Salud Pública Mex 2007;49:s436–s447.Google Scholar
- 11.Wong R, Michaels A, Palloni A. Cohort Profile:The Mexican Health and Aging Study (MHAS). Int J Epidemiol 2017;1;46(2):e2Google Scholar
- 15.Pérez MU, Sánchez N, González M, et al. Sarcopenia prevalence using simple measurements and population-based cutoff values. J Lat Am Geriatr Med 2016;2(1):8–13Google Scholar